Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple wristband replace drugs for severe morning sickness?

NCT ID NCT07613814

Symptom relief Sponsor: Universitas Sumatera Utara Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a vibratory wristband worn on the inner wrist for 15-20 minutes to reduce nausea and vomiting in 240 pregnant women with hyperemesis gravidarum (severe morning sickness). The device stimulates a pressure point (P6) thought to calm the stomach. Researchers measured symptom changes using a standard questionnaire. If effective, it could offer a non-drug option for managing this debilitating condition.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Vibratory Emesis Massage wristband (device)
What this could lead to
If it works, this could offer pregnant women a simple, drug-free way to reduce severe nausea and vomiting at home.
What could go wrong
This is a small, single-hospital study with no blinding, so results may not apply broadly. The device may not work for everyone or could cause mild skin irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

240 people

The number who actually took part.

Started

Apr 2026

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant women diagnosed with emesis gravidarum or hyperemesis gravidarum. * Gestational age within the first, second, or third trimester (with a focus on those experiencing active nausea and vomiting symptoms). * Aged between 18 and 45 years. * Admitted to or receiving care at Prof. Dr. Chairuddin Panusunan Lubis Hospital, University of North Sumatra. * Willing to participate in the study and capable of providing written informed consent. Exclusion Criteria: * Pregnant women with severe medical complications unrelated to hyperemesis (e.g., severe cardiovascular disease, active skin infections, or open wounds at the Pericardium 6 / P6 acupoint area on the wrist). * Patients receiving concurrent alternative non-pharmacological therapies for nausea and vomiting that could confound the study results. * Patients who are unable to complete the assigned 15-to-20-minute Vibratory Emesis Massage (MVE) sessions due to acute physical or cognitive distress. * Participants who choose to withdraw from the hospital treatment or study protocol before the post-test evaluation is completed.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hyperemesis gravidarum are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hyperemesis gravidarum

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hyperemesis gravidarum

Contacts and locations

Locations

  • Prof. Dr. Chairuddin Panusunan Lubis Hospital, University of North Sumatra

    Medan, North Sumatra, 20155, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.